ClinicalTrials.gov
public full text
Public Domain
Efficacy of Esketamine for Patients With Irritable Bowel Syndrome
To explore the efficacy of a single low dose of esketamine for patients with irritable bowel syndrome (IBS).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Irritable Bowel Syndrome (IBS) Treatment With H1-receptor Antagonists#880652
- Open Trial of Duloxetine in Outpatients With Irritable Bowel Syndrome Symptoms and Co-Morbid Major Depression#858239
- An Open-Label Trial of Duloxetine for the Treatment of Irritable Bowel Syndrome#869796
- Therapeutic Effect of Chang'an I Recipe on Irritable Bowel Syndrome With Diarrhea#854452
- Mystical Experience Induced by Esketamine Treatment: A Real-World Observational Study#149864
Record · ID 903327
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive